Trade Summary

3 days ago, Wentworth Kerry, serving as Chief Regulatory Officer at Nuvation Bio Inc. (NUVB), sold 200,000 shares at $4.52 per share, for a total transaction value of $903,560.00. Following this transaction, Wentworth Kerry now holds 53,000 shares of NUVB.

This sale represents a 79.00% decrease in Wentworth Kerry's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 8, 2026, 2 days after the trade was made.

Nuvation Bio Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.